# Exploring the Role of GHRP-6 in LEAP-2 Mediated Food Intake Regulation

Canonical source: https://retacompare.com/research/exploring-the-role-of-ghrp-6-in-leap-2-mediated-food-intake-regulation

Growth Hormone Peptides · 2026-02-01


    The study investigates how GHRP-6 interacts with LEAP-2 to influence food intake in broiler chickens. This research provides insights into the complex interplay between ghrelin, cannabinoid systems, and antimicrobial peptides in regulating appetite. Understanding these mechanisms may have implications for both animal and human health.

 What this study examined

The study focused on the effects of intracerebroventricular (ICV) injection of liver-expressed antimicrobial peptide 2 (LEAP-2) and its interaction with the cannabinoid and ghrelin systems on food intake in broiler chickens. Four experiments were conducted, each with four experimental groups. The groups included saline controls and varying doses of LEAP-2 and (D-Lys-3)-GHRP-6, a ghrelin receptor agonist. The cumulative meal consumption was measured at specific intervals post-administration to assess the impact on food intake.

 Why it matters for GHRP-6 research

This study is significant for GHRP-6 research as it highlights the peptide's role in modulating food intake through its interaction with LEAP-2. The findings suggest that GHRP-6 may enhance the hypophagic effects of LEAP-2, indicating a potential pathway for appetite regulation. This interaction could provide new avenues for research into appetite control mechanisms in both poultry and mammals, including humans.

 Key findings

ICV injection of LEAP-2 at doses of 1.5 and 3 nmol significantly decreased food intake.

Co-injection of (D-Lys-3)-GHRP-6 with LEAP-2 significantly reduced LEAP-2-induced hypophagia.

Co-injection of SR141716A and AM630 with LEAP-2 amplified the hypophagic effect compared to control groups.

The study suggests that LEAP-2-induced hypophagia is mediated via ghrelin and cannabinoid receptors in neonatal chickens.

Results indicate that both cannabinoid receptor antagonists and GHRP-6 can modulate the effects of LEAP-2 on food intake.

 How GHRP-6 works (background)

GHRP-6, or Growth Hormone Releasing Peptide-6, is a synthetic peptide that stimulates the secretion of growth hormone (GH) from the pituitary gland. It acts primarily through the ghrelin receptor, mimicking the action of ghrelin, a hormone known for its role in appetite stimulation and energy balance. GHRP-6 can influence various physiological processes, including metabolism and body composition. Its interaction with other systems, such as the cannabinoid system, suggests a complex regulatory network governing food intake and energy homeostasis.

 Practical takeaways for researchers

Researchers studying appetite regulation may find the interactions between GHRP-6 and LEAP-2 particularly relevant. The findings underscore the importance of considering multiple signaling pathways when investigating appetite control mechanisms. Additionally, the study highlights the potential for using GHRP-6 in combination with other peptides or antagonists to modulate food intake effectively. Future research could explore these interactions further, potentially leading to novel strategies for managing appetite in various species.

 FAQ

 What is GHRP-6 used for in research?

GHRP-6 is primarily used in research to study growth hormone secretion and its effects on metabolism and appetite regulation.

 How does GHRP-6 affect food intake?

GHRP-6 can stimulate appetite by acting on ghrelin receptors, influencing food intake and energy balance.

 Are there any known side effects of GHRP-6?

While GHRP-6 is generally considered safe for research purposes, potential side effects may include increased hunger and changes in metabolism, which should be evaluated in studies.

 Source: PubMed · Poult Sci · published 2026-02-01.

## Sources

- PubMed · Poult Sci: https://pubmed.ncbi.nlm.nih.gov/41406822/